Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Kedrion Biopharmakedrion.com · Low evidenceKedrion Biopharma is a plasma-derived biopharmaceutical company that produces therapies for rare diseases, including primary and secondary immunodeficiencies. The company is investing €150 million to triple its production capacity in Italy's 'Plasma Valley' to treat rare diseases.
Sources
cslplasma.com shapes more of what AI says about Kedrion Biopharma than any other source, at 40% of its citations.
facebook.com · goodrx.com · octapharmaplasma.com
The market map
Biotech and Health Service Providers →Where AI ranks Kedrion Biopharma